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In routine clinical practice, the child and adolescent psychiatrist must take diagnostic and therapeutic 
decisions in a context of relative “uncertainty”. Indeed, reference frameworks based on solid evidence 
offer more and more often guidelines for our strategies [1]. Protocols and tools are available in order 
to improve prescription [2], prediction [3] and prevention [4]. 
In the present issue of European Child and Adolescent Psychiatry, several papers are representative of 
this process of informed risk management geared to guarantee the effectiveness and safety of our 
interventions. 
The European guidelines group for Hyperkinetic disorders [5] have already considerably contributed 
to the delivery of guidelines for comprehensive and state of the art therapeutic strategies in ADHD [6]. 
The warnings about the possible adverse effects of ADHD medication led the group to review the 
literature and consult specialists in paediatrics, cardiology and endocrinology, examining incident 
causality and potential impact of risk. Evidence and advice are classified according to different 
domains: cardiac dysfunction, suicide-related events, growth, sleep disturbances, tics, substance 
abuse, seizures, and psychotic symptoms. The adverse side effects are usually mild or temporary. The 
very severe adverse effects such as cardiac dysfunction are extremely uncommon. A series of 
recommendations for monitoring are given, but in the end "the primary responsibility for ensuring 
the safety of the patient lies with the prescriber" through his careful appreciation of the risk-benefit 
ratio. 
The original study presented by Knook et al [7] illustrates the relevance of a joint paediatric and 
childhood psychiatric approach, previously described in 2006 [8], to detect psychiatric morbidity in 
children and adolescents initially referred to paediatric departments and outpatient clinics. They 
assessed psychiatric disorders and their predictors in children and adolescents with unexplained 
chronic musculoskeletal or abdominal pains or headache (UCP). In this at risk population they found a 
high prevalence of relevant psychiatric disorders: anxiety, affective and disruptive disorders with an 
additional risk in children presenting with headache. A careful psychiatric assessment is therefore 
recommended to detect, in the population with UCP, treatable psychiatric disorders in order to 
increase the chance that they be incorporated into a tailored treatment plan. 
Considering psychopathology from a developmental perspective and extending a previous study 
published in 2007 [9], Perren et al [10] employed a longitudinal and multi-informant approach to 
assess psychopathology in young children in order to describe the characteristics of psychosocial 
functioning that could emerge as protective or risk factor for later emotional and conduct problems. 
The interplay between self-oriented and other-oriented social skills is identified as a multifactorial 
pivot process in psychological development that could help to predict vulnerability towards later 
emotional disorders. This work opens new pathways for training and intervention that could promote 
healthy emotional development and prevent later psychopathological problems. 
This issue gathers innovative research which highlights the relevance of multidisciplinary and 
longitudinal studies in assessing the efficacy and safety of early intervention and in detecting high-risk 
groups. It is a step of major importance towards new preventive strategies in child and adolescent 
psychopathology. 
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